was read the article
array:25 [ "pii" => "S2254887419300943" "issn" => "22548874" "doi" => "10.1016/j.rceng.2019.03.020" "estado" => "S300" "fechaPublicacion" => "2019-08-01" "aid" => "1651" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "copyrightAnyo" => "2019" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Rev Clin Esp. 2019;219:320-1" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0014256519300827" "issn" => "00142565" "doi" => "10.1016/j.rce.2019.03.002" "estado" => "S300" "fechaPublicacion" => "2019-08-01" "aid" => "1651" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Rev Clin Esp. 2019;219:320-1" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 51 "formatos" => array:2 [ "HTML" => 32 "PDF" => 19 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Calidad de vida, adherencia y satisfacción en pacientes con fibrilación auricular en tratamiento anticoagulante" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "320" "paginaFinal" => "321" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Quality of life, compliance and satisfaction of patients with atrial fibrillation who are undergoing anticoagulant treatment" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Montero-Pérez-Barquero, L. Manzano" "autores" => array:2 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Montero-Pérez-Barquero" ] 1 => array:2 [ "nombre" => "L." "apellidos" => "Manzano" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2254887419300943" "doi" => "10.1016/j.rceng.2019.03.020" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887419300943?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256519300827?idApp=WRCEE" "url" => "/00142565/0000021900000006/v1_201907300642/S0014256519300827/v1_201907300642/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2254887419300566" "issn" => "22548874" "doi" => "10.1016/j.rceng.2019.03.005" "estado" => "S300" "fechaPublicacion" => "2019-08-01" "aid" => "1644" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Rev Clin Esp. 2019;219:322-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Hepatitis C is a risk factor for cardiovascular disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "322" "paginaFinal" => "323" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "La hepatitis <span class="elsevierStyleSmallCaps">C</span> es un factor de riesgo para enfermedad cardiovascular" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "V. Estrada, I. Sagastagoitia" "autores" => array:2 [ 0 => array:2 [ "nombre" => "V." "apellidos" => "Estrada" ] 1 => array:2 [ "nombre" => "I." "apellidos" => "Sagastagoitia" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0014256519300724" "doi" => "10.1016/j.rce.2019.01.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256519300724?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887419300566?idApp=WRCEE" "url" => "/22548874/0000021900000006/v1_201907300655/S2254887419300566/v1_201907300655/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2254887419300311" "issn" => "22548874" "doi" => "10.1016/j.rceng.2019.02.005" "estado" => "S300" "fechaPublicacion" => "2019-08-01" "aid" => "1598" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Rev Clin Esp. 2019;219:315-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1 "HTML" => 1 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Brief Original</span>" "titulo" => "Galectina-3 as a biomarker of acute kidney injury risk in patients with decompensated heart failure" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "315" "paginaFinal" => "319" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Galectina-3 como biomarcador de riesgo de daño renal agudo en pacientes con insuficiencia cardiaca descompensada" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1068 "Ancho" => 2489 "Tamanyo" => 149398 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Galectin-3 levels according to acute kidney injury stage.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Sanchez-Serna, M. Martinez-Villanueva, Á. Hernández-Vicente, M.C. Asensio-Lopez, J.A. Noguera, D.A. Pascual-Figal" "autores" => array:6 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Sanchez-Serna" ] 1 => array:2 [ "nombre" => "M." "apellidos" => "Martinez-Villanueva" ] 2 => array:2 [ "nombre" => "Á." "apellidos" => "Hernández-Vicente" ] 3 => array:2 [ "nombre" => "M.C." "apellidos" => "Asensio-Lopez" ] 4 => array:2 [ "nombre" => "J.A." "apellidos" => "Noguera" ] 5 => array:2 [ "nombre" => "D.A." "apellidos" => "Pascual-Figal" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0014256518303072" "doi" => "10.1016/j.rce.2018.10.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256518303072?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887419300311?idApp=WRCEE" "url" => "/22548874/0000021900000006/v1_201907300655/S2254887419300311/v1_201907300655/en/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S2254887419301109" "issn" => "22548874" "doi" => "10.1016/j.rceng.2018.12.012" "estado" => "S300" "fechaPublicacion" => "2019-08-01" "aid" => "1621" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Rev Clin Esp. 2019;219:285-92" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Quality of life, adherence and satisfaction of patients with auricular fibrillation treated with dabigatran or vitamin K antagonists" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "285" "paginaFinal" => "292" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Calidad de vida, adherencia y satisfacción en pacientes con fibrilación auricular tratados con dabigatrán o antagonistas de la vitamina K" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 824 "Ancho" => 1434 "Tamanyo" => 34373 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Appropriate treatment compliance in month 6 according to the type of anticoagulant (Morisky–Green test). <span class="elsevierStyleItalic">Abbreviation</span>: VKA, vitamin K antagonists.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "V. Barrios, C. Escobar, G. Barón Esquivias, J.J. Gómez Doblas, E. Recalde del Vigo, L. Segura Martínez, P. Alvarez Garcia, F. Alonso Valladares, J. Toril Lopez, J.M. Chopo Alcubilla" "autores" => array:10 [ 0 => array:2 [ "nombre" => "V." "apellidos" => "Barrios" ] 1 => array:2 [ "nombre" => "C." "apellidos" => "Escobar" ] 2 => array:2 [ "nombre" => "G." "apellidos" => "Barón Esquivias" ] 3 => array:2 [ "nombre" => "J.J." "apellidos" => "Gómez Doblas" ] 4 => array:2 [ "nombre" => "E." "apellidos" => "Recalde del Vigo" ] 5 => array:2 [ "nombre" => "L." "apellidos" => "Segura Martínez" ] 6 => array:2 [ "nombre" => "P." "apellidos" => "Alvarez Garcia" ] 7 => array:2 [ "nombre" => "F." "apellidos" => "Alonso Valladares" ] 8 => array:2 [ "nombre" => "J." "apellidos" => "Toril Lopez" ] 9 => array:2 [ "nombre" => "J.M." "apellidos" => "Chopo Alcubilla" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0014256519300189" "doi" => "10.1016/j.rce.2018.12.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256519300189?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887419301109?idApp=WRCEE" "url" => "/22548874/0000021900000006/v1_201907300655/S2254887419301109/v1_201907300655/en/main.assets" ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Quality of life, compliance and satisfaction of patients with atrial fibrillation who are undergoing anticoagulant treatment" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "320" "paginaFinal" => "321" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M. Montero-Pérez-Barquero, L. Manzano" "autores" => array:2 [ 0 => array:4 [ "nombre" => "M." "apellidos" => "Montero-Pérez-Barquero" "email" => array:1 [ 0 => "fm1mopem@uco.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "L." "apellidos" => "Manzano" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Medicina Interna, IMIBIC/Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Medicina Interna, Hospital Universitario Ramón y Cajal, Universidad de Alcalá (IRYCIS), Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Calidad de vida, adherencia y satisfacción en pacientes con fibrilación auricular en tratamiento anticoagulante" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Atrial fibrillation (AF) is a highly prevalent disease and is closely related to thrombotic events. International guidelines therefore firmly recommend anticoagulant therapy with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOAs).<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The health-related quality of life has been widely studied in patients treated with VKAs, but there have been few studies on patients treated with DOAs. The health-related quality of life has been assessed using various generic and specific quality-of-life tests.<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">2,3</span></a> The information provided suggests that these patients quality of life is related to the frequent monitoring visits and dietary restrictions (for VKAs) and hemorrhagic complications and limited physical activity (for both treatments).</p><p id="par0015" class="elsevierStylePara elsevierViewall">Anticoagulant therapy compliance is a highly relevant aspect, considering the risk that the incorrect taking of medication entails.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">4</span></a> Numerous studies have evaluated VKA treatment compliance; however, our understanding of compliance with DOAs is highly limited, with more than a quarter of patients presenting suboptimal compliance.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">4</span></a> In terms of patient satisfaction, the results so far are conflicting, showing dissatisfaction due to problems of anxiety and depression.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">5</span></a> In other cases the results show a lower burden and greater perceived benefit.<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">6,7</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">In this issue, the results of an interesting article by Barrios et al.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">8</span></a> are presented. The authors compared the quality of life, treatment compliance and satisfaction between patients with anticoagulated AF taking VKA or dabigatran, which was the first DOA introduced into clinical practice.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">9</span></a> The authors included more than 1000 patients treated in outpatient cardiology clinics. Quality of life was assessed using the AF-QoL test, which has been validated in Spain for this disease.<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">10</span></a> The results showed that the patients treated with dabigatran had a better quality-of-life score at 6 months of follow-up, results that differed from the reference clinical trial on dabigatran (RELY) that observed no differences in quality of life between the two treatment groups at 1 year of follow-up.<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">11</span></a> The benefit of dabigatran observed in this new study could be an accurate reflection of clinical practice, where the follow-up conditions are significantly different from those of a clinical trial.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Moreover, the article by Barrios et al. also analyzed the degree of compliance with these 2 groups of anticoagulants. It is important to note that compliance with dabigatran was very high during the 6 months of follow-up (approximately 90%), which was significantly greater than that of VKA (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.001). The authors note, however, that the follow-up period might have been too short and that the results might have been lower if the follow-up had been extended a year or more.</p><p id="par0030" class="elsevierStylePara elsevierViewall">The study's most controversial issue is the assessment of the study patients’ degree of satisfaction. While most studies have estimated this parameter with a test that assesses the degree of patient wellbeing,<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">12</span></a> the present study measured it indirectly, using a survey directed at the physicians responsible for the patients. The survey was developed <span class="elsevierStyleItalic">ad hoc</span> for this study, which collected the physician's perception of the patients’ satisfaction with the treatment.</p><p id="par0035" class="elsevierStylePara elsevierViewall">Despite these limitations, the study by Barrios et al. throws light on additional important aspects that have seldom been studied on anticoagulant therapy in patients with AF, such as quality of life and treatment compliance. The information provided by this study is a further test of the superiority of DOAs over VKA in cases of nonvalvular AF. We congratulate the authors for their contribution. Nevertheless, these results should be corroborated in future studies.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Montero-Pérez-Barquero M, Manzano L. Calidad de vida, adherencia y satisfacción en pacientes con fibrilación auricular en tratamiento anticoagulante. Rev Clin Esp. 2019;219:320–321.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:12 [ 0 => array:3 [ "identificador" => "bib0065" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Kirchhof" 1 => "S. Benussi" 2 => "D. Kotecha" 3 => "A. Ahlsson" 4 => "D. Atar" 5 => "B. Casadei" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehw210" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2016" "volumen" => "37" "paginaInicial" => "2893" "paginaFinal" => "2962" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27567408" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0070" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Health-related quality of life in atrial fibrillation patients over 65 years: a review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "L. Zhang" 1 => "R. Gallagher" 2 => "L. Neubeck" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/2047487314538855" "Revista" => array:6 [ "tituloSerie" => "Eur J Prev Cardiol" "fecha" => "2015" "volumen" => "22" "paginaInicial" => "987" "paginaFinal" => "1002" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24924742" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0075" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diferencias en la calidad de vida según el tipo de fibrilación auricular" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R. Peinado" 1 => "F. Arribas" 2 => "J.M. Ormaetxe" 3 => "X. Badía" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Esp Cardiol" "fecha" => "2010" "volumen" => "63" "paginaInicial" => "1402" "paginaFinal" => "1409" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21144400" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0080" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.T. Borne" 1 => "C. O’Donnell" 2 => "M.P. Turakhia" 3 => "P.D. Varosy" 4 => "C.A. Jackevicius" 5 => "L.N. Marzec" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s12872-017-0671-6" "Revista" => array:5 [ "tituloSerie" => "BMC Cardiovasc Disord" "fecha" => "2017" "volumen" => "17" "paginaInicial" => "236" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28865440" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0085" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: a PREFER in AF Registry substudy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. De Caterina" 1 => "B. Brüggenjürgen" 2 => "H. Darius" 3 => "S. Köhler" 4 => "M. Lucerna" 5 => "L. Pecen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.acvd.2017.04.007" "Revista" => array:6 [ "tituloSerie" => "Arch Cardiovasc Dis" "fecha" => "2018" "volumen" => "111" "paginaInicial" => "74" "paginaFinal" => "84" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28942115" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0090" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Satisfaction with oral anticoagulants in patients with atrial fibrillation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Suárez Fernández" 1 => "L. Castilla-Guerra" 2 => "J. Cantero Hinojosa" 3 => "J.M. Suriñach" 4 => "F. Acosta de Bilbao" 5 => "J.J. Tamarit" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Patient Prefer Adherence" "fecha" => "2018" "volumen" => "12" "paginaInicial" => "267" "paginaFinal" => "274" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0095" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y. Koretsune" 1 => "T. Ikeda" 2 => "K. Kozuma" 3 => "T. Hirano" 4 => "M. Yasaka" 5 => "M. Kida" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2147/PPA.S152579" "Revista" => array:6 [ "tituloSerie" => "Patient Prefer Adherence" "fecha" => "2017" "volumen" => "11" "paginaInicial" => "1987" "paginaFinal" => "1996" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29290682" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0100" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Calidad de vida, adherencia y satisfacción en pacientes con fibrilación auricular tratados con dabigatran o antagonistas de la vitamina K" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "V. Barrios" 1 => "C. Escobar" 2 => "G. Barón Esquivias" 3 => "J.J. Gómez Doblas" 4 => "E. Recalde del Vigo" 5 => "L. Segura Martínez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Clin Esp" "fecha" => "2019" "volumen" => "219" "paginaInicial" => "285" "paginaFinal" => "292" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0105" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dabigatran versus warfarin in patients with atrial fibrillation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.J. Connolly" 1 => "M.D. Ezekowitz" 2 => "S. Yusuf" 3 => "J. Eikelboom" 4 => "J. Oldgren" 5 => "A. Parekh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa0905561" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2009" "volumen" => "361" "paginaInicial" => "1139" "paginaFinal" => "1151" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19717844" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0110" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "F. Arribas" 1 => "J.M. Ormaetxe" 2 => "R. Peinado" 3 => "N. Perulero" 4 => "P. Ramirez" 5 => "X. Badia" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/europace/eup421" "Revista" => array:6 [ "tituloSerie" => "Europace" "fecha" => "2010" "volumen" => "12" "paginaInicial" => "364" "paginaFinal" => "370" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20056594" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0115" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Assessing the impact of dabigatran and warfarin on health-related quality of life: results from an RE-LY sub-study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "B.U. Monz" 1 => "S.J. Connolly" 2 => "M. Korhonen" 3 => "H. Noack" 4 => "J. Pooley" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ijcard.2013.03.059" "Revista" => array:6 [ "tituloSerie" => "Int J Cardiol" "fecha" => "2013" "volumen" => "168" "paginaInicial" => "2540" "paginaFinal" => "2547" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23664436" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0120" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Benzimra" 1 => "B. Bonnamour" 2 => "M. Duracinsky" 3 => "C. Lalanne" 4 => "J.P. Aubert" 5 => "O. Chassany" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2147/PPA.S131158" "Revista" => array:6 [ "tituloSerie" => "Patient Prefer Adherence" "fecha" => "2018" "volumen" => "12" "paginaInicial" => "79" "paginaFinal" => "87" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29379275" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/22548874/0000021900000006/v1_201907300655/S2254887419300943/v1_201907300655/en/main.assets" "Apartado" => array:4 [ "identificador" => "72714" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Editorials" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/22548874/0000021900000006/v1_201907300655/S2254887419300943/v1_201907300655/en/main.pdf?idApp=WRCEE&text.app=https://revclinesp.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887419300943?idApp=WRCEE" ]
Year/Month | Html | Total | |
---|---|---|---|
2023 March | 3 | 3 | 6 |
2020 September | 0 | 1 | 1 |